Displaying drugs 276 - 300 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Pancrelipase | 131000.0 |  | A purified form of porcine pancreatic lipase, amylase, and protease enzymes used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis. | Enzyme Preparations |
| Pancrelipase amylase | 57086.0 |  | A lipase used to treat pancreatic exocrine insufficiency. | Amylases / Amylases, antagonists & inhibitors / Glycoside Hydrolases |
| Pancrelipase lipase | 48000.0 |  | A lipase used to treat pancreatic exocrine insufficiency. | Carboxylic Ester Hydrolases / Lipase |
| Pancrelipase protease | Not Available | | A lipase used to treat pancreatic exocrine insufficiency. | Hydrolases / Peptide Hydrolases |
| Panitumumab | Not Available |  | A recombinant humanized monoclonal antibody used to treat EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. | Antibodies, Monoclonal / EGFR (Epidermal Growth Factor Receptor) inhibitors |
| Papain | Not Available | | A proteolytic enzyme derived from papaya used for its anti-inflammatory properties. | Cysteine Endopeptidases / Papain, antagonists & inhibitors |
| Parathyroid hormone | 9420.0 C408H674N126O126S2 |  | An analog of human parathyroid hormone (PTH) used to treat hypocalcemia caused by hypoparathyroidism. | Parathyroid Hormones and Analogues |
| Pegademase | 40788.2 C1821H2834N484O552S14 |  | A modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes. | Bovine Intestinal Adenosine Deaminase / Severe Combined Immunodeficiency |
| Pegaspargase | 31731.9 C1377H2208N382O442S17 |  | A modified form of L-asparagine amidohydrolase used to treat acute lymphoblastic leukemia, which is dependent on an external source of asparagine. | Asparagine-specific Enzyme / Delayed-Action Preparations |
| Pegfilgrastim | 39000.0 C845H1343N223O243S9 |  | A recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy. | Colony-Stimulating Factors |
| Peginesatide | Not Available | | Peginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis | Erythropoiesis-Stimulating Agents |
| Peginterferon alfa-2a | 60000.0 |  | A modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. | Antiviral Agents / Drug Carriers / Interferon alpha / Interferons |
| Peginterferon alfa-2b | 31000.0 |  | A purified form of human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C, genital warts, and some cancers. | Antiviral Agents / Drug Carriers / Hepatitis C / Interferon alpha / Interferons |
| Peginterferon beta-1a | 22500.0 | | An interferon beta used to treat relapsing forms of multiple sclerosis. | Interferon-beta / Interferons |
| Pegloticase | 34192.8533 C1549H2430N408O448S8 | | A recombinant uricase used for the treatment of chronic gout in adult patients refractory to conventional therapy. | Uric Acid-specific Enzyme |
| Pegunigalsidase alfa | 116000.0 C2060H3130N552O601S27 | | A recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease. | Enzymes |
| Pegvisomant | 22129.0 C990H1532N262O300S7 |  | A growth hormone receptor antagonist used to treat acromegaly. | Acromegaly / Growth Hormone Receptor Antagonist |
| Pembrolizumab | 149000.0 C6504H10004N1716O2036S46 |  | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Pepsin | Not Available | | A protease indicated in the treatment of digestive disorders. | Enzyme Preparations |
| Pertuzumab | 148000.0 |  | An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. | Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors |
| Plasma protein fraction (human) | Not Available | | A plasma protein solution used to treat coagulation factor deficiencies, reverse anticoagulant effects, and shock from a loss of plasma fluids, and is also used in plasma exchange procedures. | Plasma Substitutes |
| Plasminogen | Not Available | | Plasma-derived human plasminogen administered intravenously to treat type 1 plasminogen deficiency (hypoplasminogenemia). | Anticoagulants / Beta-Globulins / Enzyme Precursors / Fibrinolytic Agents |
| Polatuzumab vedotin | 150000.0 C6670H10317N1745O2087S40 | | A CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / Cancer immunotherapy / CD79b-directed Antibody–Drug Conjugates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Substrates / Globulins / Immunoglobulins / Immunologic Factors / Immunoproteins / Immunotherapy / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / Noxae / P-glycoprotein substrates / Proteins / Serum Globulins / Toxic Actions |
| Poractant alfa | Not Available | | A pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. | Pulmonary Surfactants / Surface-Active Agents |
| Protamine sulfate | Not Available | | A blood factor used when the reversal of the anticoagulant effect of heparin is necessary and for the treatment of heparin overdose. | Heparin Antagonists / Heparin Reversal Agent / Nuclear Proteins / Nucleoproteins |
Displaying drugs 276 - 300 of 406 in total